Leptin enhances the invasion of pancreatic cancer through the increase in matrix metalloproteinase13 (MMP-13) production via the Januskinase2(JAK2)/STAT3 signaling pathway. This evidence concerns the gene LEP and familial pancreatic carcinoma.